{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:50:45Z","timestamp":1791561045240,"version":"4.3.4"},"reference-count":54,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Coinfection with\n            <jats:named-content content-type=\"genus-species\">Plasmodium falciparum<\/jats:named-content>\n            malaria and Epstein-Barr virus (EBV) is a major risk factor for endemic Burkitt lymphoma (eBL), still one of the most prevalent pediatric cancers in equatorial Africa. Although malaria infection has been associated with immunosuppression, the precise mechanisms that contribute to EBV-associated lymphomagenesis remain unclear. In this study, we used polychromatic flow cytometry to characterize CD8\n            <jats:sup>+<\/jats:sup>\n            T-cell subsets specific for EBV-derived lytic (BMFL1 and BRLF1) and latent (LMP1, LMP2, and EBNA3C) antigens in individuals with divergent malaria exposure. No malaria-associated differences in EBV-specific CD8\n            <jats:sup>+<\/jats:sup>\n            T-cell frequencies were observed. However, based on a multidimensional analysis of CD45RO, CD27, CCR7, CD127, CD57, and PD-1 expression, we found that individuals living in regions with intense and perennial (holoendemic) malaria transmission harbored more differentiated EBV-specific CD8\n            <jats:sup>+<\/jats:sup>\n            T-cell populations that contained fewer central memory cells than individuals living in regions with little or no (hypoendemic) malaria. This profile shift was most marked for EBV-specific CD8\n            <jats:sup>+<\/jats:sup>\n            T-cell populations that targeted latent antigens. Importantly, malaria exposure did not skew the phenotypic properties of either cytomegalovirus (CMV)-specific CD8\n            <jats:sup>+<\/jats:sup>\n            T cells or the global CD8\n            <jats:sup>+<\/jats:sup>\n            memory T-cell pool. These observations define a malaria-associated aberration localized to the EBV-specific CD8\n            <jats:sup>+<\/jats:sup>\n            T-cell compartment that illuminates the etiology of eBL.\n          <\/jats:p>","DOI":"10.1128\/jvi.02158-12","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T01:44:21Z","timestamp":1353635061000},"page":"1779-1788","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":42,"title":["Holoendemic Malaria Exposure Is Associated with Altered Epstein-Barr Virus-Specific CD8\n            <sup>+<\/sup>\n            T-Cell Differentiation"],"prefix":"10.1128","volume":"87","author":[{"given":"Pratip K.","family":"Chattopadhyay","sequence":"first","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiprotich","family":"Chelimo","sequence":"additional","affiliation":[{"name":"Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula B.","family":"Embury","sequence":"additional","affiliation":[{"name":"Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Mulama","sequence":"additional","affiliation":[{"name":"Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Odada","family":"Sumba","sequence":"additional","affiliation":[{"name":"Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Gostick","sequence":"additional","affiliation":[{"name":"Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Ladell","sequence":"additional","affiliation":[{"name":"Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess M.","family":"Brodie","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vulule","sequence":"additional","affiliation":[{"name":"Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Roederer","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Moormann","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School, Worcester, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Price","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Cardiff University School of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.18004619704"},{"key":"e_1_3_3_3_2","first-page":"1","article-title":"Age incidence in Burkitt's lymphoma syndrome","volume":"41","author":"Haddow AJ","year":"1964","unstructured":"HaddowAJ. 1964. Age incidence in Burkitt's lymphoma syndrome. East Afr. Med. J. 41:1\u20136.","journal-title":"East Afr. Med. J."},{"key":"e_1_3_3_4_2","first-page":"S68","article-title":"Burkitt's lymphoma in Kenya: geographical, age, gender and ethnic distribution","volume":"8","author":"Mwanda OW","year":"2004","unstructured":"MwandaOW RochfordR MoormannAM MacneilA WhalenC WilsonML. 2004. Burkitt's lymphoma in Kenya: geographical, age, gender and ethnic distribution. East Afr. Med. J. 8:S68\u2013S77.","journal-title":"East Afr. Med. J."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70175-X"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(64)91524-7"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1381.1999.t01-1-99220.x"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2015"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1962.03050380004002"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910060102"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2007.01875.x"},{"issue":"2","key":"e_1_3_3_12_2","first-page":"3","article-title":"Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study\u2014a review","volume":"11","author":"de The G","year":"1975","unstructured":"de TheG DayNE GeserA LavoueMF HoJH SimonsMJ SohierR TukeiP VonkaV ZavadovaH. 1975. Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study\u2014a review. IARC Sci. Publ. 11(Pt 2):3\u201316.","journal-title":"IARC Sci. Publ."},{"key":"e_1_3_3_13_2","first-page":"1147","article-title":"Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups","volume":"43","author":"Henle G","year":"1969","unstructured":"HenleG HenleW CliffordP DiehlV KafukoGW KiryaBG KleinG MorrowRH MunubeGM PikeP TukeiPM ZieglerJL. 1969. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J. Natl. Cancer Inst. 43:1147\u20131157.","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141553"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.54.1.19"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.405"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.1.241.001a19_241_248"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.4.2019"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.76.995"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2003.68.68"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.10.005"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910310609"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/312449a0"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/511984"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/500839"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/428910"},{"key":"e_1_3_3_27_2","first-page":"724","article-title":"Immunological control of human lymphoma: discussion","volume":"36","author":"Klein E","year":"1976","unstructured":"KleinE KleinG LevinPH. 1976. Immunological control of human lymphoma: discussion. Cancer Res. 36:724\u2013727.","journal-title":"Cancer Res."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.9.5412-5418.2004"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.24.7837"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328349ac4f"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1089"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0320(20010901)45:1<47::AID-CYTO1143>3.0.CO;2-A"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0320(20010901)45:1<56::AID-CYTO1144>3.0.CO;2-9"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/526787"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-2815.2004.00192.x"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051357"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.20945"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7183.600a"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2103"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0208107"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024852"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062363"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2446"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(03)80010-X"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70069-0"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb02568.x"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24014"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)90569-7"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030080"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21485"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.6.1215-1220.1991"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/274756a0"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910290406"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809742106"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.162"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.02158-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.02158-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T15:38:06Z","timestamp":1646494686000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.02158-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1128\/JVI.02158-12"],"URL":"https:\/\/doi.org\/10.1128\/jvi.02158-12","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"2012-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-11-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-01-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}